• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同程度慢性肾脏病对经皮冠状动脉介入治疗患者长期预后的影响。

Effect of Various Degrees of Chronic Kidney Disease on Long-term Outcome of Patients with Percutaneous Coronary Intervention.

机构信息

Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.

Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Arch Iran Med. 2019 May 1;22(5):247-251.

PMID:31256597
Abstract

BACKGROUND

We aimed to identify the association of degree of renal failure in chronic kidney disease patients who underwent percutaneous coronary intervention (PCI) at our center with 5-year major adverse cardiac events (MACE).

METHODS

In this cohort study, we enrolled all patients who underwent primary or elective PCI and completed their 5-year followup unless they developed events related to study end-points. Demographic, angiographic and clinical data of the participants were retrieved from our databank. Glomerular filtration rate (GFR) was calculated based on the Cockcroft-Gault equation for men and women, separately. Accordingly, our patients were classified into three groups: GFR ≥ 60, GFR < 60 and ≥30 and GFR < 30 mL/ min. Then, the demographic and clinical data, as well as the frequency of MACE and its elements, were compared between the study groups.

RESULTS

We included the data for 5,510 patients. MACE occurred in 891 (16.1%) of the patients. A total of 632 cases (16.7%) occurred in patients with GFR > 60 while 224 cases (18.8%) and 35 events (43.7%) occurred in patients with 30 ≤ GFR < 60 and GFR < 30 mL/min, respectively. So, GFR < 30 mL/min was significant predictor for MACE (hazard ratio [HR] = 3.74, 95% CI: 2.64-5.28; P < 0.001). The prediction effect of GFR < 30 remained significant after adjustment for the confounding variables (HR = 3.43, 95% CI: 2.38-4.94; P < 0.001).

CONCLUSION

GFR <30 mL/min was a strong predictor for 5-year MACE. Moreover, in patients with GFR > 30 mL/min, PCI is a more applicable approach.

摘要

背景

本研究旨在探讨我院行经皮冠状动脉介入治疗(PCI)的慢性肾脏病患者肾功能衰竭程度与 5 年主要不良心脏事件(MACE)的相关性。

方法

本队列研究纳入了所有在我院行择期或急诊 PCI 并完成 5 年随访的患者,除非发生与研究终点相关的事件。从我们的数据库中检索参与者的人口统计学、血管造影和临床数据。肾小球滤过率(GFR)分别根据 Cockcroft-Gault 方程计算男性和女性的 GFR。因此,我们将患者分为三组:GFR≥60、GFR<60 且≥30 和 GFR<30 mL/min。然后,比较研究组之间的人口统计学和临床数据,以及 MACE 及其各元素的发生率。

结果

我们纳入了 5510 例患者的数据。MACE 发生在 891 例(16.1%)患者中。GFR>60 的患者中有 632 例(16.7%)发生 MACE,GFR 为 30≤GFR<60 的患者中有 224 例(18.8%)和 35 例(43.7%)发生 MACE,GFR<30 的患者中有 35 例(43.7%)发生 MACE。因此,GFR<30 mL/min 是 MACE 的显著预测因素(危险比[HR] = 3.74,95%CI:2.64-5.28;P<0.001)。在调整混杂因素后,GFR<30 mL/min 的预测效果仍然显著(HR = 3.43,95%CI:2.38-4.94;P<0.001)。

结论

GFR<30 mL/min 是 5 年 MACE 的强烈预测因素。此外,在 GFR>30 mL/min 的患者中,PCI 是一种更适用的治疗方法。

相似文献

1
Effect of Various Degrees of Chronic Kidney Disease on Long-term Outcome of Patients with Percutaneous Coronary Intervention.不同程度慢性肾脏病对经皮冠状动脉介入治疗患者长期预后的影响。
Arch Iran Med. 2019 May 1;22(5):247-251.
2
Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.轻至中度慢性肾脏病对经皮冠状动脉介入治疗后一年预后的影响。
Nephron. 2017;137(1):23-28. doi: 10.1159/000473863. Epub 2017 May 6.
3
Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.接受经皮冠状动脉介入治疗的慢性肾脏病ST段抬高型心肌梗死患者的预后:马来西亚国家心血管疾病数据库——2007年至2014年经皮冠状动脉介入治疗(NCVD-PCI)注册数据。
BMC Cardiovasc Disord. 2018 Sep 24;18(1):184. doi: 10.1186/s12872-018-0919-9.
4
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials.经皮冠状动脉介入治疗中药物洗脱支架治疗女性慢性肾脏病的效果:随机对照试验的患者水平汇总分析。
JACC Cardiovasc Interv. 2016 Jan 11;9(1):28-38. doi: 10.1016/j.jcin.2015.09.023.
5
Predictors of Long-term Major Adverse Cardiac Events Following Percutaneous Coronary Intervention in the Elderly.老年患者经皮冠状动脉介入治疗后长期主要不良心脏事件的预测因素
Arch Iran Med. 2018 Aug 1;21(8):344-348.
6
Survival and long-term cardiovascular outcomes after carotid endarterectomy in patients with chronic renal insufficiency.慢性肾功能不全患者行颈动脉内膜切除术后的生存情况及长期心血管结局
Ann Vasc Surg. 2015 Jan;29(1):15-21. doi: 10.1016/j.avsg.2014.07.029. Epub 2014 Sep 3.
7
Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.接受经皮冠状动脉介入治疗的慢性肾脏病患者的五年死亡率结局
Catheter Cardiovasc Interv. 2017 Mar 1;89(4):E124-E132. doi: 10.1002/ccd.26664. Epub 2016 Aug 13.
8
Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.肾功能不全严重程度对行经皮冠状动脉介入治疗患者住院死亡率相关因素的影响。
Catheter Cardiovasc Interv. 2012 Sep 1;80(3):352-7. doi: 10.1002/ccd.23394. Epub 2012 May 4.
9
Everolimus Eluting Stents in Patients with Diabetes Mellitus and Chronic Kidney Disease: Insights from the TUXEDO Trial.依维莫司洗脱支架在糖尿病合并慢性肾脏病患者中的应用:TUXEDO试验的见解
Cardiovasc Revasc Med. 2019 Dec;20(12):1075-1080. doi: 10.1016/j.carrev.2019.02.017. Epub 2019 Feb 28.
10
Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.慢性肾脏病(CKD)患者与非CKD患者经皮冠状动脉介入治疗后外周血管内皮功能障碍对后续心血管事件的不同影响。
Heart Vessels. 2016 Jul;31(7):1038-44. doi: 10.1007/s00380-015-0713-x. Epub 2015 Jul 12.

引用本文的文献

1
The prognostic utility of GRACE risk score in predictive adverse cardiovascular outcomes in patients with NSTEMI and multivessel disease.GRACE 风险评分在预测非 ST 段抬高型心肌梗死伴多血管病变患者不良心血管结局中的预后价值。
BMC Cardiovasc Disord. 2022 Dec 26;22(1):568. doi: 10.1186/s12872-022-03025-6.
2
Dose-dependent effect of impaired renal function on all-cause mortality in patients following percutaneous coronary intervention.肾功能受损对经皮冠状动脉介入治疗后患者全因死亡率的剂量依赖性影响。
Clin Cardiol. 2022 Aug;45(8):882-891. doi: 10.1002/clc.23877. Epub 2022 Jun 27.